Eckert & Ziegler Receives Approval for Gallium-68 Generator for Canada

Country selection

To offer the best possible experience tailored to your national regulatory requirements and the available product portfolio, please choose your country from the following list. This option will be saved throughout the browser session. Thank you!

User experience & privacy

We use cookies to offer you an optimal website experience. This includes cookies necessary for the operation of the website and for the control of our commercial corporate goals, as well as those only used for anonymous statistical purposes, comfort settings or to display personalized content. Please note that based on your settings, not all functions of the website may be available. To find out more, please refer to our Data Privacy Statement.

25/08/2020

Berlin, Germany

Eckert & Ziegler Radiopharma GmbH has received approval for its pharmaceutical ⁶⁸Ge/⁶⁸Ga generator GalliaPharm^® from the Canadian regulatory authority Health Canada.

“We are pleased to now be able to offer GalliaPharm^® in Canada. Meanwhile, the generators from Eckert & Ziegler are available in more and more countries. If gallium-based diagnostics become widely accepted in the coming years, we are well prepared as supplier”, explains Dr. Lutz Helmke, member of the Executive Board of Eckert & Ziegler AG and responsible for the Medical segment. “Since there are currently many clinical studies with so-called theranostics worldwide, we expect an increasing demand for both the diagnostic radioisotope gallium-68 and the therapeutic radioisotope lutetium-177 in the next few years”.

To read the full press release, please refer to www.ezag.com

Contact

Get in touch

Permission required

In order to submit your request it is required to load a 3rd-party service (Google Re-Captcha spam protection system). You current privacy settings prevent this from happening automatically. By clicking the button below you explicitly allow to temporarily (on this page) load 3rd party services.

Allow